Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
4.735
-0.395 (-7.70%)
At close: Oct 9, 2025, 4:00 PM EDT
4.700
-0.035 (-0.74%)
After-hours: Oct 9, 2025, 4:03 PM EDT
SONN Market Cap
SONN has a market cap or net worth of $32.33 million as of October 9, 2025. Its market cap has increased by 558.32% in one year.
Market Cap
32.33M
Enterprise Value
34.77M
1-Year Change
558.32%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $32.33M, a decrease of -44.36%. That is a compound annual growth rate of -10.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 35.02M | 697.67% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
| Apr 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |